What were Calumet Inc's Q2 2026 earnings per share (EPS) and net loss, and how did they compare to analyst expectations?

Calumet Inc reported a Q2 2026 EPS of $(1.09) and a net loss of $95.9 million, significantly missing analyst estimates of $(0.34) per share. Although revenue came in at $1.445 billion — exceeding expectations — the large negative EPS was driven primarily by an unrealized non-cash loss related to Renewable Identification Numbers (RINs). Despite the earnings miss, the company showed improved operational execution, with Adjusted EBITDA reaching $175.2 million.

What key financial and governance red flags does the news highlight for Calumet Inc investors?

The news highlights several cautionary signals for investors: GuruFocus rates Calumet Inc as 161.9% overvalued and assigns it a low financial strength score; additionally, recent insider selling is noted as a further cause for concern. These factors — combined with the substantial Q2 earnings miss driven by a non-cash RIN-related loss — underscore heightened investment risk despite the revenue beat and improved Adjusted EBITDA.

ChemBrief

Topics Daily Digest Tags

Is Calumet Inc (CLMT) Recovering? Q2 Earnings Show EPS at -1.09

Aug 8, 2026

Calumet Inc reported a Q2 net loss of $95.9 million with EPS of $(1.09), missing analyst estimates despite exceeding revenue expectations. Adjusted EBITDA reached $175.2 million, offsetting some concerns from unrealized RINs losses.

GuruFocus

2026-08-07

Calumet (NASDAQ:CLMT) Surprises With Strong Q2 CY2026 Results

2026-08-07

Calumet Specialty Products Partners Reports Second Quarter 2026 Results

2026-08-07

Calumet, Inc. Reports Q2 2026 Earnings Results

2026-08-08

Calumet, Inc. Reports Q2 Revenue $1.45 Billion, Surpassing Estimates

2026-08-08

Calumet Inc. Reports Q2 2026 Revenue of $1.45B, EPS ($1.09)